Biogen (BIIB) P/B (1999 - 2026)
Biogen (BIIB) P/B from Nov 1, 1999 to Jun 2, 2026. The TTM Biogen (BIIB) P/B is 1.49. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Biogen (BIIB)
| Year | P/B | Change |
|---|---|---|
| 2026 | 1.49 | +5.45% |
| 2025 | 1.41 | +6.02% |
| 2024 | 1.33 | -48.48% |
| 2023 | 2.59 | -17.35% |
| 2022 | 3.13 | -3.95% |
| 2021 | 3.26 | -9.24% |
| 2020 | 3.59 | -15.16% |
| 2019 | 4.23 | -11.24% |
| 2018 | 4.77 | -9.64% |
| 2017 | 5.28 | +2.95% |
| 2016 | 5.13 | -33.03% |
| 2015 | 7.65 | +2.98% |
| 2014 | 7.43 | -3.34% |
| 2013 | 7.69 | +54.64% |
| 2012 | 4.97 | +15.87% |
| 2011 | 4.29 | +43.98% |
| 2010 | 2.98 | +19.96% |
| 2009 | 2.48 | +106.73% |
| 2008 | 1.20 | +167.53% |
| 2007 | 0.45 | +15.71% |
| 2006 | 0.39 | +8.64% |
| 2005 | 0.36 | -32.02% |
| 2004 | 0.53 | +81.50% |
| 2003 | 0.29 | +10.64% |
| 2002 | 0.26 | -51.88% |
| 2001 | 0.54 | +9.09% |
| 2000 | 0.50 | +92.94% |
| 1999 | 0.26 | N/A |
Comparison Biogen (BIIB) P/B with competitors
Biogen (BIIB) P/B is 1.49.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.67 | -55.24% |
| GRFS | Grifols SA | 0.86 | -42.16% |
| SNY | Sanofi | 1.25 | -15.99% |
| PFE | Pfizer Inc | 1.66 | +11.26% |
| OGN | Organon & Company | 3.88 | +160.49% |
| GSK | GSK Plc | 4.30 | +188.27% |
| MIRA | Mira Pharmaceuticals Inc | 4.90 | +228.74% |
| BMY | Bristol-Myers Squibb Company | 5.91 | +296.58% |
| AZN | Astrazeneca plc | 6.07 | +307.31% |
| NVO | Novo Nordisk | 6.24 | +318.72% |
| MRK | Merck & Co Inc | 6.47 | +334.15% |
| JNJ | Johnson & Johnson | 6.86 | +360.32% |
| GILD | Gilead Sciences Inc | 7.06 | +373.74% |
| NVS | Novartis AG | 7.49 | +402.60% |
| MDCX | MDCorp | 13.18 | +784.41% |
| NSRX | Nasus Pharma Ltd | 14.22 | +854.20% |
| AMGN | AMGEN Inc | 19.74 | +1224.61% |
| SCLX | Scilex Holding Company | 28.85 | +1835.91% |
| LLY | Lilly(Eli) & Company | 30.95 | +1976.83% |
| ABBV | Abbvie Inc | 50.46 | +3286.00% |